Viewing Study NCT05895578



Ignite Creation Date: 2024-05-06 @ 7:06 PM
Last Modification Date: 2024-10-26 @ 3:00 PM
Study NCT ID: NCT05895578
Status: RECRUITING
Last Update Posted: 2024-01-17
First Post: 2023-05-19

Brief Title: Effect of a Probiotic on the Urinary Tract Microbiota of Participants With Recurrent Urinary Tract Infection
Sponsor: ProbiSearch SL
Organization: ProbiSearch SL

Study Overview

Official Title: Randomized Double-blind Placebo-controlled Study to Evaluate the Effect of a Probiotic on the Urinary Tract Microbiota in Women With Recurrent Urinary Tract Infections rUTI
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PROBUTI
Brief Summary: Urinary tract infections UTIs are the most common bacterial infections in women 50 of women experiencing at least one UTI in their lifetime with an annual prevalence of 05-07

An interventional randomized double-blind placebo-controlled study will be conducted to investigate the effect of a probiotic strains on the urinary tract microbiota in participants with recurrent urinary tract infection rUTI

The study duration will be 6 and a half months including 6 months product intake Participants will be randomly assigned to one of the three study groups control group with placebo administration probiotic administration group 1 dose and probiotic administration group 2 doses
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None